Showing results (321-330 of 432) with videos related to

Sort By:
Pageof 44
Neurology|January 29, 2003
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophyM J Eikelenboom, A Petzold, R H C Lazeron, et al.
Neurology|October 27, 2004
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosisK Rejdak, M J Eikelenboom, A Petzold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2010
Cerebrospinal fluid ATP metabolites in multiple sclerosisG Lazzarino, A M Amorini, M J Eikelenboom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosisR H C Lazeron, J B Boringa, M Schouten, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2014
Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration?I D Kilsdonk, M D Steenwijk, P J W Pouwels, et al.
Neurology|January 6, 2012
Postmortem verification of MS cortical lesion detection with 3D DIRA Seewann, E-J Kooi, S D Roosendaal, et al.
Dementia and Geriatric Cognitive Disorders|April 15, 2010
Neurological signs in relation to white matter hyperintensity volumes in memory clinic patientsS S Staekenborg, H de Waal, F Admiraal-Behloul, et al.
Neurology|October 10, 2007
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very oldF Barkhof, T M Polvikoski, E C W van Straaten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosisL J Balk, M D Steenwijk, P Tewarie, et al.
Pageof 44